A West Nile virus mutant with increased resistance to acid-induced inactivation

Journal of General Virology

Volumn 92, Issue 4, 2011, Pages 831-840

  Martín Acebes, Miguel A ^a   Saiz, Juan Carlos ^a  

^a INIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E;

ACIDIFICATION; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOSOME; ENVIRONMENTAL FACTOR; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS GENOME; VIRUS INACTIVATION; VIRUS ISOLATION; VIRUS MUTANT; VIRUS RESISTANCE; WEST NILE FLAVIVIRUS;

ACIDS; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; DNA MUTATIONAL ANALYSIS; MICE; MUTANT PROTEINS; VIRAL ENVELOPE PROTEINS; VIRUS INACTIVATION; VIRUS INTERNALIZATION; WEST NILE VIRUS;

FLAVIVIRUS; MUS; WEST NILE VIRUS;

EID: 79955752088     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.027185-0     Document Type: Article

References (53)

1. Brinton, M. A. (2002). The molecular biology of West Nile Virus: a new invader of the western hemisphere. Annu Rev Microbiol 56, 371-402.
2. Chanel-Vos, C. & Kielian, M. (2004). A conserved histidine in the ij loop of the Semliki Forest virus E1 protein plays an important role in membrane fusion. J Virol 78, 13543-13552.
3. Chu, J. J. & Ng, M. L. (2004a). Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J Virol 78, 10543-10555.
4. Chu, J. J. & Ng, M. L. (2004b). Interaction of West Nile virus with avb3 integrin mediates virus entry into cells. J Biol Chem 279, 54533-54541.
5. Ciota, A. T., Ngo, K. A., Lovelace, A. O., Payne, A. F., Zhou, Y., Shi, P.-Y. & Kramer, L. D. (2007). Role of the mutant spectrum in adaptation and replication of West Nile virus. J Gen Virol 88, 865-874.
6. Có rdoba, L., Escribano-Romero, E., Garmendia, A. & Saiz, J. C. (2007). Pregnancy increases the risk of mortality in West Nile virusinfected mice. J Gen Virol 88, 476-480.
7. Davis, C. W., Nguyen, H.-Y., Hanna, S. L., Sánchez, M. D., Doms, R. W. & Pierson, T. C. (2006). West Nile virus discriminates between DCSIGN and DC-SIGNR for cellular attachment and infection. J Virol 80, 1290-1301.
8. DeBiasi, R. L. & Tyler, K. L. (2006). West Nile virus meningoencephalitis. Nat Clin Pract Neurol 2, 264-275.
9. Diamond, M. S. (2009). Progress on the development of therapeutics against West Nile virus. Antiviral Res 83, 214-227.
10. Ebel, G. D., Carricaburu, J., Young, D., Bernard, K. A. & Kramer, L. D. (2004). Genetic and phenotypic variation of West Nile virus in New York, 2000-2003. Am J Trop Med Hyg 71, 493-500.
11. Fritz, R., Stiasny, K. & Heinz, F. X. (2008). Identification of specific histidines as pH sensors in flavivirus membrane fusion. J Cell Biol 183, 353-361.
12. Gollins, S. W. & Porterfield, J. S. (1986). The uncoating and infectivity of the flavivirus West Nile on interaction with cells: effects of pH and ammonium chloride. J Gen Virol 67, 1941-1950.
13. Guirakhoo, F., Hunt, A. R., Lewis, J. G. & Roehrig, J. T. (1993). Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology 194, 219-223.
14. Harrison, S. C. (2008). The pH sensor for flavivirus membrane fusion. J Cell Biol 183, 177-179.
15. Hayes, E. B., Komar, N., Nasci, R. S., Montgomery, S. P., O'Leary, D. R. & Campbell, G. L. (2005a). Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis 11, 1167-1173.
16. Hayes, E. B., Sejvar, J. J., Zaki, S. R., Lanciotti, R. S., Bode, A. V. & Campbell, G. L. (2005b). Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 11, 1174-1179.
17. Jerzak, G., Bernard, K. A., Kramer, L. D. & Ebel, G. D. (2005). Genetic variation in West Nile virus from naturally infected mosquitoes and birds suggests quasispecies structure and strong purifying selection. J Gen Virol 86, 2175-2183.
18. Kampmann, T., Mueller, D. S., Mark, A. E., Young, P. R. & Kobe, B. (2006). The role of histidine residues in low-pH-mediated viral membrane fusion. Structure 14, 1481-1487.
19. Kampmann, T., Yennamalli, R., Campbell, P., Stoermer, M. J., Fairlie, D. P., Kobe, B. & Young, P. R. (2009). In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Antiviral Res 84, 234-241.
20. Kanai, R., Kar, K., Anthony, K., Gould, L. H., Ledizet, M., Fikrig, E., Marasco, W. A., Koski, R. A. & Modis, Y. (2006). Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J Virol 80, 11000-11008.
21. Kaufmann, B., Nybakken, G. E., Chipman, P. R., Zhang, W., Diamond, M. S., Fremont, D. H., Kuhn, R. J. & Rossmann, M. G. (2006). West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody. Proc Natl Acad Sci U S A 103, 12400-12404.
22. Kaufmann, B., Chipman, P. R., Holdaway, H. A., Johnson, S., Fremont, D. H., Kuhn, R. J., Diamond, M. S. & Rossmann, M. G. (2009). Capturing a flavivirus pre-fusion intermediate. PLoS Pathog 5, e1000672.
23. Kilpatrick, A. M., Meola, M. A., Moudy, R. M. & Kramer, L. D. (2008). Temperature, viral genetics, and the transmission of West Nile virus by Culex pipiens mosquitoes. PLoS Pathog 4, e1000092.
24. Kimura, T. & Ohyama, A. (1988). Association between the pHdependent conformational change of West Nile flavivirus E protein and virus-mediated membrane fusion. J Gen Virol 69, 1247-1254.
25. Krishnan, M. N., Sukumaran, B., Pal, U., Agaisse, H., Murray, J. L., Hodge, T. W. & Fikrig, E. (2007). Rab 5 is required for the cellular entry of dengue and West Nile viruses. J Virol 81, 4881-4885.
26. Lanciotti, R. S., Roehrig, J. T., Deubel, V., Smith, J., Parker, M., Steele, K., Crise, B., Volpe, K. E., Crabtree, M. B. & other authors (1999). Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286, 2333-2337.
27. Lee, E., Hall, R. A. & Lobigs, M. (2004). Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J Virol 78, 8271-8280.
28. a values. Proteins 61, 704-721.
29. Liao, M., Sánchez-SanMartín, C., Zheng, A. & Kielian, M. (2010). In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein. J Virol 84, 5730-5740.
30. Maier, C. C., Delagrave, S., Zhang, Z.-X., Brown, N., Monath, T. P., Pugachev, K. V. & Guirakhoo, F. (2007). A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirus. Virology 362, 468-474.
31. Martín-Acebes, M. A., Rincó n, V., Armas-Portela, R., Mateu, M. G. & Sobrino, F. (2010). A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to acid-dependent uncoating inhibition. J Virol 84, 2902-2912.
32. Mateo, R. & Mateu, M. G. (2007). Deterministic, compensatory mutational events in the capsid of foot-and-mouth disease virus in response to the introduction of mutations found in viruses from persistent infections. J Virol 81, 1879-1887.
33. Medigeshi, G. R., Hirsch, A. J., Streblow, D. N., Nikolich-Zugich, J. & Nelson, J. A. (2008). West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of avb3 integrin. J Virol 82, 5212-5219.
34. Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. (2004). Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313-319.
35. Moesker, B., Rodenhuis-Zybert, I. A., Meijerhof, T., Wilschut, J. & Smit, J. M. (2010). Characterization of the functional requirements of West Nile virus membrane fusion. J Gen Virol 91, 389-393.
36. Moudy, R. M., Meola, M.A., Morin, L.-L., Ebel, G.D., Kramer, L.D. (2007). A newly emergent genotype of West Nile virus is transmitted earlier and more efficiently by Culex mosquitoes. Am J Trop Med Hyg 77, 365-370.
37. Mueller, D. S., Kampmann, T., Yennamalli, R., Young, P. R., Kobe, B. & Mark, A. E. (2008). Histidine protonation and the activation of viral fusion proteins. Biochem Soc Trans 36, 43-45.
38. Mukhopadhyay, S., Kim, B. S., Chipman, P. R., Rossmann, M. G. & Kuhn, R. J. (2003). Structure of West Nile virus. Science 302, 248.
39. Nayak, V., Dessau, M., Kucera, K., Anthony, K., Ledizet, M. & Modis, Y. (2009). Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J Virol 83, 4338-4344.
40. Nelson, S., Poddar, S., Lin, T.-Y. & Pierson, T. C. (2009). Protonation of individual histidine residues is not required for the pH-dependent entry of West Nile virus: evaluation of the ''histidine switch'' hypothesis. J Virol 83, 12631-12635.
41. Nybakken, G. E., Nelson, C. A., Chen, B. R., Diamond, M. S. & Fremont, D. H. (2006). Crystal structure of the West Nile virus envelope glycoprotein. J Virol 80, 11467-11474.
42. Oliphant, T., Engle, M., Nybakken, G. E., Doane, C., Johnson, S., Huang, L., Gorlatov, S., Mehlhop, E., Marri, A. & other authors (2005). Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med 11, 522-530.
43. Perera, R., Khaliq, M. & Kuhn, R. J. (2008). Closing the door on flaviviruses: entry as a target for antiviral drug design. Antiviral Res 80, 11-22.
44. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C. & Ferrin, T. E. (2004). UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem 25, 1605-1612.
45. Poh, M. K., Yip, A., Zhang, S., Priestle, J. P., Ma, N. L., Smit, J. M., Wilschut, J., Shi, P.-Y., Wenk, M. R. & Schul, W. (2009). A small molecule fusion inhibitor of dengue virus. Antiviral Res 84, 260-266.
46. Sánchez-San Martín, C., Liu, C. Y. & Kielian, M. (2009). Dealing with low pH: entry and exit of alphaviruses and flaviviruses. Trends Microbiol 17, 514-521.
47. Schmidt, A. G., Yang, P. L. & Harrison, S. C. (2010). Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog 6, e1000851.
48. Smithburn, K. C., Hughes, T. P., Burke, A. W. & Paul, J. H. (1940). A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg s1-20, 471-492.
49. Srivastava, J., Barber, D. L. & Jacobson, M. P. (2007). Intracellular pH sensors: design principles and functional significance. Physiology (Bethesda) 22, 30-39.
50. Stiasny, K., Kössl, C., Lepault, J., Rey, F. A. & Heinz, F. X. (2007). Characterization of a structural intermediate of flavivirus membrane fusion. PLoS Pathog 3, e20.
51. Stiasny, K., Fritz, R., Pangerl, K. & Heinz, F. X. (2009). Molecular mechanisms of flavivirus membrane fusion. Amino Acids. doi:10.1007/s00726-009-0370-4.
52. Thompson, B. S., Moesker, B., Smit, J. M., Wilschut, J., Diamond, M. S. & Fremont, D. H. (2009). A therapeutic antibody against West Nile virus neutralizes infection by blocking fusion within endosomes. PLoS Pathog 5, e1000453.
53. Vogt, M. R., Moesker, B., Goudsmit, J., Jongeneelen, M., Austin, S. K., Oliphant, T., Nelson, S., Pierson, T. C., Wilschut, J. & other authors (2009). Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step. J Virol 83, 6494-6507.